1. Home
  2. People
  3. Faculty
  4. Brian Chih-Hung Chiu

Brian Chih-Hung Chiu

Professor
bchiu@uchicago.edu
Research Summary
Dr. Chiu investigates the causes and outcomes of lymphoma and multiple myeloma in racial/ethnic and geographic diverse population using integrated modern molecular techniques and epidemiologic approaches. His main focus areas are: (1) studying modifiable nutritional, lifestyle, and environmental factors that are responsible for causing lymphoma and multiple myeloma, (2) identifying lifestyle, tumor, and treatment-related factors that influence survival, treatment response disparities, and outcomes of patients using cohorts of lymphoma and multiple myeloma patients as well as real world big data, and (3) developing novel epigenetics-based biomarkers for prognostication and management of patients using a liquid biopsy approach. He is also an active researcher in large international consortia, including the International Lymphoma Epidemiology Consortium (InterLymph), International Multiple Myeloma Consortium (now InterLymph-Myeloma Working Group) where he served as its chair in 2013, and the AsiaLymph.
Keywords
Non-Hodgkin Lymphoma, Multiple Myeloma, Health disparities, Molecular epidemiology, Epigenetics, Liquid biopsy, Translational population research
Biosciences Graduate Program Association
Publications

  1. Geospatial analysis of population-based incidence of multiple myeloma in the United States. Cancer Epidemiol. 2023 Apr; 83:102343. View in: PubMed

  2. Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma. Cancers (Basel). 2022 Oct 29; 14(21). View in: PubMed

  3. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 2022 12; 36(12):2835-2844. View in: PubMed

  4. Physical activity and the risk of non-Hodgkin lymphoma subtypes: A pooled analysis. Int J Cancer. 2023 02 01; 152(3):396-407. View in: PubMed

  5. Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma. J Hematol Oncol. 2022 08 16; 15(1):106. View in: PubMed

  6. Sanfilippo syndrome type A: early cardiac involvement of two patients with cardiac manifestations. Cardiovasc Pathol. 2022 Sep-Oct; 60:107430. View in: PubMed

  7. Physical functioning, frailty and risks of locally-advanced breast cancer among older women. Breast. 2022 Aug; 64:19-28. View in: PubMed

  8. Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data. PLoS One. 2022; 17(3):e0265543. View in: PubMed

  9. Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators. Haematologica. 2022 04 01; 107(4):966-969. View in: PubMed

  10. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma. Sci Rep. 2021 12 08; 11(1):23664. View in: PubMed

  11. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Breast Cancer. 2022 Mar; 29(2):287-295. View in: PubMed

  12. Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410. View in: PubMed

  13. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Res Treat. 2021 Oct; 189(3):769-779. View in: PubMed

  14. Disparities in diagnosis, treatment and survival between Black and White Parkinson patients. Parkinsonism Relat Disord. 2021 06; 87:7-12. View in: PubMed

  15. Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma. NPJ Genom Med. 2021 Feb 11; 6(1):11. View in: PubMed

  16. Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncol Pract. 2021 03; 17(3):e294-e312. View in: PubMed

  17. Sex differences in outcomes in multiple myeloma. Br J Haematol. 2021 02; 192(3):e66-e69. View in: PubMed

  18. Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis. Blood Cancer J. 2020 08 07; 10(8):80. View in: PubMed

  19. Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States. JCO Oncol Pract. 2020 10; 16(10):e1169-e1180. View in: PubMed

  20. Self-reported health and survival in older patients diagnosed with multiple myeloma. Cancer Causes Control. 2020 Jul; 31(7):641-650. View in: PubMed

  21. Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies. Ann Oncol. 2012 Sep; 23(9):2362-2374. View in: PubMed

  22. Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis. Ann Oncol. 2012 Aug; 23(8):2128-2137. View in: PubMed

  23. Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma. Int J Cancer. 2020 09 01; 147(5):1300-1305. View in: PubMed

  24. A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry. Blood Adv. 2020 01 14; 4(1):181-190. View in: PubMed

  25. Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma. Support Care Cancer. 2020 Sep; 28(9):4097-4106. View in: PubMed

  26. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults. Medicine (Baltimore). 2019 Nov; 98(46):e17960. View in: PubMed

  27. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv. 2019 10 08; 3(19):2790-2799. View in: PubMed

  28. Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma. Epigenomes. 2019 Sep; 3(3). View in: PubMed

  29. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. 2019 12; 68(12):2195-2205. View in: PubMed

  30. Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Causes Control. 2019 Aug; 30(8):889-900. View in: PubMed

  31. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Commun (Lond). 2019 03 29; 39(1):12. View in: PubMed

  32. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Cancer. 2019 04 01; 125(7):1143-1154. View in: PubMed

  33. Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia. J Geriatr Oncol. 2019 05; 10(3):510-513. View in: PubMed

  34. Pooled study of occupational exposure to aromatic hydrocarbon solvents and risk of multiple myeloma. Occup Environ Med. 2018 11; 75(11):798-806. View in: PubMed

  35. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions. Int J Cancer. 2018 09 01; 143(5):1062-1071. View in: PubMed

  36. Cardiovascular dysfunction in sepsis at the dawn of emerging mediators. Biomed Pharmacother. 2017 Nov; 95:153-160. View in: PubMed

  37. Autophagy-Inflammasome Interplay in Heart Failure: A Systematic Review on Basics, Pathways, and Therapeutic Perspectives. Ann Clin Lab Sci. 2017 May; 47(3):243-252. View in: PubMed

  38. Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiol Biomarkers Prev. 2017 06; 26(6):876-885. View in: PubMed

  39. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev. 2016 12; 25(12):1609-1618. View in: PubMed

  40. Early Bronchus-Associated Lymphoid Tissue Lymphoma Diagnosed with Immunoglobulin Heavy Chain Molecular Testing. Can Respir J. 2016; 2016:7056035. View in: PubMed

  41. Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma. Leuk Lymphoma. 2017 02; 58(2):343-347. View in: PubMed

  42. Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium. Br J Haematol. 2016 Oct; 175(1):87-101. View in: PubMed

  43. Evaluation of Automatically Assigned Job-Specific Interview Modules. Ann Occup Hyg. 2016 Aug; 60(7):885-99. View in: PubMed

  44. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet. 2016 Apr 15; 25(8):1663-76. View in: PubMed

  45. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium. Environ Health Perspect. 2016 Apr; 124(4):396-405. View in: PubMed

  46. Epidemiology and etiology of non-hodgkin lymphoma. Cancer Treat Res. 2015; 165:1-25. View in: PubMed

  47. A genome-wide association study of marginal zone lymphoma shows association to the HLA region. Nat Commun. 2015 Jan 08; 6:5751. View in: PubMed

  48. A pooled analysis of cigarette smoking and risk of multiple myeloma from the international multiple myeloma consortium. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):631-4. View in: PubMed

  49. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. Am J Hum Genet. 2014 Oct 02; 95(4):462-71. View in: PubMed

  50. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet. 2014 Nov; 46(11):1233-8. View in: PubMed

  51. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):130-44. View in: PubMed

  52. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):52-65. View in: PubMed

  53. Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):26-40. View in: PubMed

  54. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):1-14. View in: PubMed

  55. Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model. Br J Cancer. 2014 Aug 12; 111(4):708-15. View in: PubMed

  56. The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras. Am J Hematol. 2014 Jun; 89(6):633-8. View in: PubMed

  57. The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era. Leuk Lymphoma. 2014 Dec; 55(12):2778-84. View in: PubMed

  58. Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy. PLoS One. 2013; 8(9):e75336. View in: PubMed

  59. A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas. Leuk Lymphoma. 2014 Jun; 55(6):1288-94. View in: PubMed

  60. A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1620-7. View in: PubMed

  61. Pre-diagnosis cigarette smoking and overall survival in non-Hodgkin lymphoma. Br J Haematol. 2013 Nov; 163(3):352-6. View in: PubMed

  62. Relative validity and reproducibility of a quantitative FFQ for assessing nutrient intakes of vegetarians in Taiwan. Public Health Nutr. 2014 Jul; 17(7):1459-66. View in: PubMed

  63. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev. 2013 Jul; 22(7):1252-9. View in: PubMed

  64. Dietary patterns and the risk of non-Hodgkin lymphoma. Public Health Nutr. 2014 Jul; 17(7):1531-7. View in: PubMed

  65. Three-dimensional segmentation of three-dimensional ultrasound carotid atherosclerosis using sparse field level sets. Med Phys. 2013 May; 40(5):052903. View in: PubMed

  66. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol. 2013 Aug; 20(8):2746-53. View in: PubMed

  67. Dietary intake of fruits and vegetables and overall survival in non-Hodgkin lymphoma. Leuk Lymphoma. 2013 Dec; 54(12):2613-9. View in: PubMed

  68. Multiple myeloma and occupation: a pooled analysis by the International Multiple Myeloma Consortium. Cancer Epidemiol. 2013 Jun; 37(3):300-5. View in: PubMed

  69. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA. Leuk Lymphoma. 2013 Aug; 54(8):1677-83. View in: PubMed

  70. Assessment of femoral artery atherosclerosis at the adductor canal using 3D black-blood MRI. Clin Radiol. 2013 Apr; 68(4):e213-21. View in: PubMed

  71. Toward a global understanding of lymphoma: epidemiologic clues from the second most populous country. Leuk Lymphoma. 2013 May; 54(5):901-2. View in: PubMed

  72. Endothelin axis is upregulated in human and rat right ventricular hypertrophy. Circ Res. 2013 Jan 18; 112(2):347-54. View in: PubMed

  73. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium. Cancer Causes Control. 2013 Jan; 24(1):125-34. View in: PubMed

  74. Phytanic acid and the risk of non-Hodgkin lymphoma. Carcinogenesis. 2013 Jan; 34(1):170-5. View in: PubMed

  75. Dietary nitrate and nitrite intake and risk of non-Hodgkin lymphoma. Leuk Lymphoma. 2013 May; 54(5):945-50. View in: PubMed

  76. Meat intake and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2012 Oct; 23(10):1681-92. View in: PubMed

  77. Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies. Ann Oncol. 2012 Sep; 23(9):2362-2374. View in: PubMed

  78. Increased stroke risk in Bell's palsy patients without steroid treatment. Eur J Neurol. 2013 Apr; 20(4):616-22. View in: PubMed

  79. Increased risk of vascular events in emergency room patients discharged home with diagnosis of dizziness or vertigo: a 3-year follow-up study. PLoS One. 2012; 7(4):e35923. View in: PubMed

  80. Abnormal air collection on plain abdominal X-ray. Intern Med J. 2012 Jan; 42(1):101-2. View in: PubMed

  81. Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Int J Cancer. 2012 Nov 15; 131(10):2342-8. View in: PubMed

  82. Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis. Ann Oncol. 2012 Aug; 23(8):2128-2137. View in: PubMed

  83. Fruit, vegetables, fibre and micronutrients and risk of US renal cell carcinoma. Br J Nutr. 2012 Sep 28; 108(6):1077-85. View in: PubMed

  84. Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2011 Aug; 22(8):1183-95. View in: PubMed

  85. Patient morbidity and management patterns of community-based primary health care services in Hong Kong. Hong Kong Med J. 2011 Jun; 17(3 Suppl 3):33-7. View in: PubMed

  86. Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol. 2011 May; 22(5):1170-1180. View in: PubMed

  87. Birth order and risk of non-hodgkin lymphoma--true association or bias? Am J Epidemiol. 2010 Sep 15; 172(6):621-30. View in: PubMed

  88. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010 Nov 18; 116(20):e90-8. View in: PubMed

  89. Decellularization reduces immunogenicity of sheep pulmonary artery vascular patches. J Thorac Cardiovasc Surg. 2011 Apr; 141(4):1056-62. View in: PubMed

  90. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009 Aug 15; 69(16):6482-9. View in: PubMed

  91. Pesticides, chromosomal aberrations, and non-Hodgkin's lymphoma. J Agromedicine. 2009; 14(2):250-5. View in: PubMed

  92. Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study. Growth Horm IGF Res. 2009 Oct; 19(5):420-5. View in: PubMed

  93. From gene expression to serum proteins: biomarker discovery in ankylosing spondylitis. Ann Rheum Dis. 2010 Jan; 69(1):297-300. View in: PubMed

  94. Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study. Cancer Causes Control. 2009 Jul; 20(5):517-23. View in: PubMed

  95. The challenges of epidemiologic research in non-Hodgkin lymphoma. JAMA. 2008 Nov 05; 300(17):2059-61. View in: PubMed

  96. Dietary fat and risk of renal cell carcinoma in the USA: a case-control study. Br J Nutr. 2009 Apr; 101(8):1228-38. View in: PubMed

  97. The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J Natl Cancer Inst Monogr. 2008; (39):69-73. View in: PubMed

  98. Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma. Cancer Causes Control. 2008 Oct; 19(8):859-67. View in: PubMed

  99. Physical activity, physical function, and the risk of breast cancer in a prospective study among elderly women. J Gerontol A Biol Sci Med Sci. 1998 Jul; 53(4):M251-6. View in: PubMed

  100. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008 Apr 15; 111(8):4029-38. View in: PubMed

  101. Obesity and immigration among Latina women. J Immigr Minor Health. 2009 Oct; 11(5):428-31. View in: PubMed

  102. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008 May 01; 122(9):2062-70. View in: PubMed

  103. Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics. 2007 Nov; 59(11):839-52. View in: PubMed

  104. Associations of physical activity, sedentary time, and insulin with percent breast density in Hispanic women. J Womens Health (Larchmt). 2007 Sep; 16(7):1004-11. View in: PubMed

  105. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer. 2008 Jan 01; 122(1):144-54. View in: PubMed

  106. Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study. Eur J Cancer. 2007 Nov; 43(16):2388-95. View in: PubMed

  107. Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study. Psychoneuroendocrinology. 2007 Sep-Nov; 32(8-10):951-8. View in: PubMed

  108. Obesity and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control. 2007 Aug; 18(6):677-85. View in: PubMed

  109. Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma. Am J Epidemiol. 2007 Mar 15; 165(6):652-9. View in: PubMed

  110. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007 Apr 15; 109(8):3479-88. View in: PubMed

  111. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2348-54. View in: PubMed

  112. Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone Study. Int J Obes (Lond). 2007 Apr; 31(4):685-91. View in: PubMed

  113. Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer. Am J Pathol. 2006 Aug; 169(2):633-42. View in: PubMed

  114. Q fever endocarditis: a case report and review of the literature. Can J Cardiol. 2006 Jul; 22(9):781-5. View in: PubMed

  115. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood. 2006 Aug 15; 108(4):1363-9. View in: PubMed

  116. Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obes (Lond). 2006 Jun; 30(6):940-7. View in: PubMed

  117. IGF-1, IGFBP-3, and nutritional factors in young black and white men: the CARDIA Male Hormone Study. Nutr Cancer. 2005; 53(1):57-64. View in: PubMed

  118. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol. 2005 Jul; 6(7):469-76. View in: PubMed

  119. Predictors of prostate cancer screening among health fair participants. Public Health. 2005 Aug; 119(8):686-93. View in: PubMed

  120. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):925-33. View in: PubMed

  121. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study. Br J Haematol. 2005 Mar; 128(5):610-5. View in: PubMed

  122. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):2208-16. View in: PubMed

  123. Changes in diet during adult life and risk of colorectal adenomas. Nutr Cancer. 2004; 49(1):49-58. View in: PubMed

  124. Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):525-31. View in: PubMed

  125. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma. 2003 Dec; 4(3):161-8. View in: PubMed

  126. Chlamydia pneumoniae and atherosclerosis following carotid endarterectomy. Can J Neurol Sci. 2003 Nov; 30(4):333-9. View in: PubMed

  127. The relationship between agricultural environments and olfactory dysfunction. J Agric Saf Health. 2003 Aug; 9(3):211-9. View in: PubMed

  128. Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2003 Mar; 12(3):201-8. View in: PubMed

  129. Update on epidemiology and therapeutics for non-Hodgkin's lymphoma. Hematology Am Soc Hematol Educ Program. 2002; 241-62. View in: PubMed

  130. Does asbestos exposure cause non-Hodgkin's lymphoma or related hematolymphoid cancers? A review of the epidemiologic literature. Clin Lymphoma. 2002 Jun; 3(1):36-40. View in: PubMed

  131. Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob Agents Chemother. 2002 Aug; 46(8):2321-6. View in: PubMed

  132. Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men. Ann Epidemiol. 2002 Jul; 12(5):309-15. View in: PubMed

  133. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J Infect Dis. 2002 Jun 01; 185(11):1621-30. View in: PubMed

  134. Transplanting a kidney with a renal artery aneurysm--a case report and literature review. Vasc Surg. 2001 Jul-Aug; 35(4):321-4. View in: PubMed

  135. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia. J Immunol. 2001 Sep 15; 167(6):3375-82. View in: PubMed

  136. Murine aortic aneurysm produced by periarterial application of calcium chloride. J Surg Res. 2001 Aug; 99(2):371-6. View in: PubMed

  137. Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):413-4. View in: PubMed

  138. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann Epidemiol. 2001 Jan; 11(1):28-37. View in: PubMed

  139. Rescuing acute rejection of rat cardiac allografts with FTY720. Transplant Proc. 2000 Nov; 32(7):1629-30. View in: PubMed

  140. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res. 2000 Oct 01; 60(19):5365-70. View in: PubMed

  141. Silicone gel implant capsules and Chlamydia antigens. Plast Reconstr Surg. 2000 Jul; 106(1):225-6. View in: PubMed

  142. Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance. Infect Immun. 2000 Mar; 68(3):1243-51. View in: PubMed

  143. Transrectal ultrasound assessment of murine aorta and iliac arteries. J Surg Res. 2000 Feb; 88(2):193-9. View in: PubMed

  144. Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? Clin Diagn Lab Immunol. 1999 Nov; 6(6):891-4. View in: PubMed

  145. Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women. Br J Cancer. 1999 Jul; 80(9):1476-82. View in: PubMed

  146. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev. 1999 Jan; 8(1):53-60. View in: PubMed

  147. Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women. Am J Clin Nutr. 1999 Jan; 69(1):147-52. View in: PubMed

  148. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997 Oct 07; 96(7):2144-8. View in: PubMed

  149. Diet and risk of non-Hodgkin lymphoma in older women. JAMA. 1996 May 01; 275(17):1315-21. View in: PubMed

  150. Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas. Clin Exp Metastasis. 1995 Nov; 13(6):492-8. View in: PubMed

  151. Analysis of hyaluronic acid in the diagnosis of malignant mesothelioma. Cancer. 1984 Nov 15; 54(10):2195-9. View in: PubMed

  152. Parathyroid hormone-like peptide in normal and neoplastic mesothelial cells. Cancer. 1990 Nov 01; 66(9):1975-9. View in: PubMed

  153. Immunoepidemiology of post-Salmonella reactive arthritis in a cohort of women. Clin Immunol Immunopathol. 1992 Sep; 64(3):227-32. View in: PubMed
© 2023 The University of Chicago | All Rights Reserved.
Facebook Instagram Twitter Youtube